| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | BRD-K88742110 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | isonicotinohydroxamic acid | CTRPv2 | pan-cancer | AAC | -0.026 | 0.6 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |